Alvogen Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Alvogen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013130
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alvogen Inc (Alvogen) develops, manufactures and markets biosimilar products, generic pharmaceuticals and OTC products. The company’s product portfolio comprises generic medications in various therapeutic areas that include oncology, cardiology, respiratory, neurology and gastroenterology. Alvogen also focuses on the product development, contract manufacturing and research. It offers products in various forms such as solid oral dosage, modified release tablets, soft gelatin capsules, creams, ointments, transdermals and injectables. The company has operational presence with regional hubs, manufacturing, research and development capabilities in the US, South Korea and Romania. Alvogen is headquartered in Pinebrook, New Jersey, the US.

Alvogen Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alvogen Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Alvogen Inc, Medical Devices Deals, 2011 to YTD 2017 9
Alvogen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Alvogen Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Lotus Pharma Acquires Osteoporosis from Novartis 12
Alvogen Acquires Five Hormonal Products from Bayer Pharma 13
Alvogen to Acquire Four Pharma Products from Pfizer 14
Private Equity 15
CVC Capital, Temasek and Vatera Healthcare Partners Acquire Majority Stake in Alvogen 15
Pamplona Capital Management Acquires Majority Stake In Alvogen 17
Partnerships 18
Lotus Pharma, Tzu Chi Hospital and EF Biotech to Enter into Agreement 18
Alvogen Enters into Marketing Agreement with AstraZeneca 19
Probi Enters Into Distribution Agreement With Alvogen 20
Licensing Agreements 21
Luye Pharma Enters into Licensing Agreement with Lotus Pharma 21
TMRC Enters Into Licensing Agreement With EPS And Lotus Pharma For TM-411 22
Asset Transactions 23
Lotus Pharma Plans to Sell Product Rights 23
Acquisition 24
CVC Capital, Temasek and Vatera Healthcare May Sell Alvogen for up to USD4 Billion 24
Alvogen to Acquire Omega Bittner from Perrigo 25
Alvogen to Acquire County Line Pharmaceuticals 26
Alvogen Acquires Dream Pharma for USD184 Million 27
Alvogen To Acquire 67% Stake In Lotus Pharma For US$205 Million 28
Alvogen Completes Acquisition Of 67% Stake In KunWha Pharma For US$68 Million 29
Alvogen Completes Acquisition Of LaborMed Pharma, Maker Of Generic Drugs 30
Alvogen Inc – Key Competitors 31
Alvogen Inc – Key Employees 32
Alvogen Inc – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 35
Strategy And Business Planning 35
Aug 02, 2016: Alvogen Kicks off in Thailand 35
Corporate Communications 36
Jan 13, 2016: Regional management changes to accelerate APAC strategy 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Alvogen Inc, Pharmaceuticals & Healthcare, Key Facts 2
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alvogen Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alvogen Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Alvogen Inc, Medical Devices Deals, 2011 to YTD 2017 9
Alvogen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Lotus Pharma Acquires Osteoporosis from Novartis 12
Alvogen Acquires Five Hormonal Products from Bayer Pharma 13
Alvogen to Acquire Four Pharma Products from Pfizer 14
CVC Capital, Temasek and Vatera Healthcare Partners Acquire Majority Stake in Alvogen 15
Pamplona Capital Management Acquires Majority Stake In Alvogen 17
Lotus Pharma, Tzu Chi Hospital and EF Biotech to Enter into Agreement 18
Alvogen Enters into Marketing Agreement with AstraZeneca 19
Probi Enters Into Distribution Agreement With Alvogen 20
Luye Pharma Enters into Licensing Agreement with Lotus Pharma 21
TMRC Enters Into Licensing Agreement With EPS And Lotus Pharma For TM-411 22
Lotus Pharma Plans to Sell Product Rights 23
CVC Capital, Temasek and Vatera Healthcare May Sell Alvogen for up to USD4 Billion 24
Alvogen to Acquire Omega Bittner from Perrigo 25
Alvogen to Acquire County Line Pharmaceuticals 26
Alvogen Acquires Dream Pharma for USD184 Million 27
Alvogen To Acquire 67% Stake In Lotus Pharma For US$205 Million 28
Alvogen Completes Acquisition Of 67% Stake In KunWha Pharma For US$68 Million 29
Alvogen Completes Acquisition Of LaborMed Pharma, Maker Of Generic Drugs 30
Alvogen Inc, Key Competitors 31
Alvogen Inc, Key Employees 32
Alvogen Inc, Subsidiaries 33

★海外企業調査レポート[Alvogen Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hasbro, Inc.:企業の戦略・SWOT・財務情報
    Hasbro, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hasbro, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Visteon Corp (VC):企業の財務・戦略的SWOT分析
    Visteon Corp (VC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • 3-D Matrix Ltd (7777):製薬・医療:M&Aディール及び事業提携情報
    Summary 3-D Matrix Ltd (3-D Matrix) is a regenerative medicine company that focuses at commercializing its self-assembling peptide technology. It develops medical products by applying this technology under a license granted by Massachusetts Institute of Technology (MIT). The technology finds applica …
  • leon-nanodrugs GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Leon-Nanodrugs GmbH (Leon-Nanodrugs) is a drug development company that discovers and develops nanotechnology based drug delivery systems. The company develops oral and parenteral products. Its products portfolio includes nanoparticles and drug-delivery-systems such as functionalized multila …
  • ADVA Optical Networking SE (ADV):企業の財務・戦略的SWOT分析
    ADVA Optical Networking SE (ADV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Petrofac Ltd (PFC):企業の財務・戦略的SWOT分析
    Petrofac Ltd (PFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Georgetown University:製薬・医療:M&Aディール及び事業提携情報
    Summary Georgetown University (GU) is an academic and research institute that offers educational services. The university provides undergraduate and graduate degree programs in the fields of law, medical, medical residencies, business administration and public policy degrees, post-doctoral positions …
  • Worldpay, Inc.:企業の財務・戦略的SWOT分析
    Worldpay, Inc. - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Translate Bio Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Translate Bio Inc (Translate Bio), formerly RaNA Therapeutics Inc is a healthcare service provider that develops therapies which targets RNA within cells in the body to selectively activate protein expression. The company provides platform oligonucleotides (oligos) are molecules designed to …
  • Panasonic Homes Co., Ltd.:企業の戦略的SWOT分析
    Panasonic Homes Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Green Plains Inc.:企業のM&A・事業提携・投資動向
    Green Plains Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Green Plains Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Peregrine Pharmaceuticals Inc (PPHM)-製薬・医療分野:企業M&A・提携分析
    Summary Peregrine Pharmaceuticals Inc (Peregrine) is a biopharmaceutical company that develops and manufactures monoclonal antibodies for the treatment and diagnosis of cancer. The company’s products include Bavituximab, PGN650 and Cotara. Its Bavituximab is a monoclonal antibody that binds to a bas …
  • Deciphera Pharmaceuticals LLC (DCPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Deciphera Pharmaceuticals LLC (Deciphera Pharmaceuticals) is a research and development company that develops, designs, and commercializes kinase inhibiting drugs. The company provides clinical pipeline of kinase inhibitors such as tumor-targeted therapies and immuno-targeted therapies. It u …
  • Ajanta Pharma Ltd (AJANTPHARM):企業の財務・戦略的SWOT分析
    Ajanta Pharma Ltd (AJANTPHARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Sumatec Resources Bhd (SUMATEC):石油・ガス:M&Aディール及び事業提携情報
    Summary Sumatec Resources Bhd (Sumatec) is an oilfield service provider that offers of construction and drilling services to the oil and gas industry. The company’s services include engineering and construction for oil and gas facilities, oil and gas assets development, supply and management of onsh …
  • Bellerophon Therapeutics Inc (BLPH):企業の財務・戦略的SWOT分析
    Summary Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly Known as Bellerophon Therapeutics LLC is a clinical-stage biotherapeutics company that focuses on the development of therapies for the treatment of cardiopulmonary diseases. The company’s lead investigational cardiopulmonary p …
  • Global Payments Inc. (GPN):企業の財務・戦略的SWOT分析
    Global Payments Inc. (GPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • GGP Inc:戦略・SWOT・企業財務分析
    GGP Inc - Strategy, SWOT and Corporate Finance Report Summary GGP Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • NuGEN Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NuGEN Technologies Inc (NuGEN) is a provider of biological science reagents. The company provides DNA and RNA sample preparation products for use in research and diagnostic applications. Its products include Next-Gen Sequencing applications, which include RNA-Seq, targeted resequencing of DN …
  • Arup Group Ltd:企業の戦略的SWOT分析
    Arup Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆